ALLK Share Price Performance
US$0.33
-0.86 (-72.34%)
Price US$0.33
Share Pricen/a
Allakos Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
ALLK Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Allakos Inc. Key Details
About ALLK
- Founded
- 2012
- Employees
- 131
- CEO
- WebsiteView website
Allakos Inc., a clinical stage biotechnology company, engages in the development of therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company was incorporated in 2012 and is headquartered in San Carlos, California.
